Abiopharma

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0000950103-26-012238 <b>Size:</b> 392 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001213900-26-088265 <b>Size:</b> 238 KB

New Form SCHEDULE 13G/A - APTARGROUP, INC. <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0000895421-26-000221 <b>Size:</b> 8 KB

📋 Gibson Christopher (Ex-Director) plans to sell 50K shares of RECURSION PHARMACEUTICALS, INC. (at $3.37 each, total $168K) Filed: Aug 12, 2026 | ID: 005928

New Form SCHEDULE 13G - INSPERITY, INC. <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001418660-26-000024 <b>Size:</b> 224 KB

New Form SCHEDULE 13G - Aptiv PLC <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0000313028-26-000037 <b>Size:</b> 6 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001213900-26-088261 <b>Size:</b> 357 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001918704-26-023560 <b>Size:</b> 436 KB

New Form SCHEDULE 13G/A - AFFILIATED MANAGERS GROUP, INC. <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0000895421-26-000220 <b>Size:</b> 12 KB

New Form 13F-HR - StoneX Group Inc. <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0000913760-26-000039 <b>Size:</b> 739 KB